Leida Zhang

Prof. Dr. Leida Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
YGYi Gong
Yi Gong
HDHai-Su Dai
Hai-Su Dai
JSJun-Jie Shu
Jun-Jie Shu
WLWei Liu
Wei Liu
PBPing Bie
Ping Bie
LZLeida Zhang
Leida Zhang
Pancreatic cancer is a highly invasive malignant tumor of the digestive system. To explore the mechanism of pancreatic cancer development, development, invasion and metastasis, in this study we focused on long non-coding RNA (LncRNA), which has been reported to be involved in tumorigenesis. We identified a LINC00673, which is highly correlated with the pancreatic cancer risk. LINC00673 Overexpression is associated with good survival in pancreatic cancer patients, Effects of LINC00673 on pancreatic cancer cell apoptosis, viability, migration. LINC00673 negatively correlated with miR-504 and MiR-504 overexpression promoted cancer progression in Pancreatic cancer. MiR-504 negatively correlated with HNF1A, which was highly expressed Pancreatic cancer. HNF1A inhibited cell progression in pancreatic cancer cells. LINC00673 overexpression inhibited caner progression in nude mice. Taken together, LINC00673 can through suppress miR-504/ HNF1A regulating invasion and migration in pancreatic cancer. Also, we identified miR-504 as a target of LINC00673 in pancreatic cancer and LINC00673 can be used as a novel therapeutic target for the pancreatic cancer.

22 May 2021 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
YLYuancheng Li
Yuancheng Li
XLXingchao Liu
Xingchao Liu
YJYan Jiang
Yan Jiang
KWKun Wan
Kun Wan
WLWei Liu
Wei Liu
LZLeida Zhang
Leida Zhang
Background: As a nutritional index, preoperative serum prealbumin highly correlates with surgical complications. However, the correlation between preoperative prealbumin and postoperative complications remains unclear in liver transplantation (LT). Methods: A total of 191 patients who underwent LT between 2015 and 2019 were included in the retrospective analysis. According to a cut-off value calculated from a receiver operating characteristic (ROC) curve, the patients were divided into normal and low preoperative prealbumin groups. Univariable and multivariable logistic regression analyses were used to identify independent risk factors for postoperative complications. In addition, patients were divided into subgroups by Model for End-stage Liver Disease (MELD) score, and the association between preoperative prealbumin and postoperative complications was also assessed in each group. Results: A total of 111 (58.1%) patients were included in the low prealbumin group based on a cut-off value of 120 mg/L. The area under the ROC curve (AUC) was 0.754 (95% confidence interval [CI] 0.678–0.832). Low prealbumin (95% CI 1.51–12.8, P = 0.007) was identified as a predictor for postoperative complications based on multivariable regression. In the low and normal prealbumin groups, the prevalence rates of postoperative complications were 27.5% and 8.0% (P = 0.003) in the MELD score ≤ 15 subgroup and 53.3% and 20.0% (P = 0.197) in the MELD score > 15 subgroup, respectively. Conclusions: Preoperative prealbumin was associated with postoperative complications in LT, and preoperative nutritional support benefitted postoperative recovery, especially for patients with low MELD scores.

18 April 2025 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
FHFeng Hu
Feng Hu
YLYuancheng Li
Yuancheng Li
HZHongfei Zeng
Hongfei Zeng
RJRenhua Ju
Renhua Ju
DJDi Jiang
Di Jiang
CZCheng-Cheng Zhang
Cheng-Cheng Zhang
INTRODUCTION: The risk factors of biliary complications (BCs) after liver transplantation are not comprehensively determined. BCs also vary in times of onset. Machine learning (ML) can reveal regularities based on large-scale data to make predictions and have demonstrated good performance in liver transplantation. However, whether ML can be an efficient tool for BC prediction was not determined. METHODS: Five hundred seventeen patients from 2 centers were enrolled. Patients were randomly divided into training and validation sets at 3:1 ratio. K-fold cross-validation and the synthetic minority oversampling technique were used to debug the models, which were evaluated by receiver operating characteristic curves. SHapley Additive exPlanation values and Sankey diagrams were applied to visualize the results. Seven ML algorithms were administrated to build models for BCs prediction at 3, 6, and 12 months. RESULTS: Among all the models, support vector machine produced the highest area under curve values in predicting BCs (3-month = 0.916; 6-month = 0.892; 12-month = 0.885). According to the analysis of support vector machine, the 3-month risk factors of BCs and corresponding SHapley Additive exPlanation value ranges were donor age (−0.13, 0.21), Model for End-Stage Liver Disease score (−0.15, 0.18), neoplastic disease (−0.14, 0.28), diabetes (−0.12, 0.27), hypertension (−0.13, 0.21), and intraoperative blood transfusion (−0.09, 0.25), whereas 6-month factors were recipient age (−0.14, 0.16), donor body mass index (−0.10, 0.13), recipient body mass index (−0.13, 0.23), and diabetes (−0.12, 0.43). The 12-month risk factors were recipient age (−0.14, 0.19), diabetes (−0.13, 0.25), and basiliximab (−0.16, 0.24). The Sankey diagram enabled clear visualization of the contribution of individual risk factors to the model in different times of BCs onset. DISCUSSION: The ML algorithm was able to identify risk factors of BCs in all postoperative periods and this supplied insights in patient management.

1 February 2022 in HepatoBiliary Surgery and Nutrition
Verified
Journal Article
Open access
PDF file
RTRui Tang
Rui Tang
CLChao Li
Chao Li
GWGuangdong Wu
Guangdong Wu
XTXuan Tong
Xuan Tong
LYLihan Yu
Lihan Yu
QLQian Lu
Qian Lu
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study Rui Tang, Chao Li, Guangdong Wu, Xuan Tong, Lihan Yu, Huayuan Hao, Rui Liao, Yucheng Hou, Jun Li, Wenping Zhao, Tieyan Fan, Leida Zhang, Qian Lu

3 January 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
BPBi Pan
Bi Pan
YLYuancheng Li
Yuancheng Li
XWXiaojun Wang
Xiaojun Wang
YOYanjiao Ou
Yanjiao Ou
GHGang Heng
Gang Heng
CZChengcheng Zhang
Chengcheng Zhang

15 April 2020 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YLYuan‐Deng Luo
Yuan‐Deng Luo
HYHong‐Qiang Yu
Hong‐Qiang Yu
XLXiao‐Yu Liu
Xiao‐Yu Liu
DHDeng Huang
Deng Huang
HDHai‐Su Dai
Hai‐Su Dai
CXChuan-Ming Xie
Chuan-Ming Xie
Purpose: Hepatocellular carcinoma (HCC) is a common malignant cancer and the third leading cause of death worldwide. The molecular mechanism of HCC remains unclear. Recent studies have demonstrated that the ubiquitin‐proteasome system (UPS) is associated with HCC. Ubqln2, a member of the UPS, is abnormally expressed in HCC. However, whether Ubqln2 is associated with HCC prognosis remains unknown.Patients and Methods: We analyzed the associations between overall survival and various risk factors in 355 HCC tissue samples obtained from the Cancer Genomic Atlas (TCGA) database at the mRNA level and in 166 HCC tissue samples from Southwest Hospital at the protein level. qRCR was used to determinate Ubqln2 expression in cancer and noncancerous tissues. The association between Ubqln2 and Ki‐67 was analyzed by immunohistochemistry. The association between Ubqln2 expression and survival was analyzed using Kaplan‐Meier curve and Cox proportional hazards models. A nomogram was used to predict the impact of Ubqln2 on prognosis. Mutated genes were analyzed to determine the potential mechanism.Results: Ubqln2 highly expressed in HCC tissues. The Ubqln2 mRNA level had significant relations with UICC tumor stage (P = .022), UICC stage (P = .034) and resection potential (P = .017). Concordantly, the Ubqln2 protein was closely associated with tumor size (P = .005), UICC stage (P = .012), and recurrence (P = .009). Ubqln2 was highly expressed in HCC and positively associated with poor survival. The nomogram precisely predicted the prognosis of HCC patients with high or low Ubqln2 expression. A genomic waterfall plot suggested that Ubqln2 expression was closely associated with mutated CTNNB1.Conclusion: Our findings reveal that Ubqln2, an independent risk factor for HCC, is a potential prognostic marker in HCC patients. Ubqln2 expression is positively associated with mutated CTNNB1.